Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - TOTAL CURRENT LIABILITIES
Total Current Liabilities YMAB - Y-mAbs Therapeutics, Inc.
20.1 M
LAST VALUE
-15.02%
2 YEAR CAGR
17.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR